Skip to main content
. Author manuscript; available in PMC: 2016 Jan 16.
Published in final edited form as: Nature. 2015 Jun 1;523(7560):347–351. doi: 10.1038/nature14406

Extended Data Figure 1.

Extended Data Figure 1

D4A is detectable in prostate cancer patients treated with Abi acetate. a, Mass spectrometry tracings of Abi and D4A in the serum of 12 patients treated with Abi acetate. Blood was drawn between 2 and 14 hours after the administration of the 1000 mg daily dose. b, Duration of Abi acetate therapy and time from last dose to blood draw for individual patients.